Ovarian cancer and hormone replacement therapy in the Million Women Study (Q34629811)

3 August 2017

title

Ovarian cancer and hormone replacement therapy in the Million Women Study (English)

1 reference

Hormone Replacement Therapy

3 August 2017

1 reference

1 reference

1

Valerie Beral

1 reference

Million Women Study Collaborators

3 August 2017

series ordinal

2

object named as

Million Women Study Collaborators

1 reference

3 August 2017

5

Gillian Reeves

1 reference

3 August 2017

Diana Bull

3

1 reference

3 August 2017

Jane Green

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

369

1 reference

3 August 2017

issue

9574

1 reference

3 August 2017

page(s)

1703-1710

1 reference

Menopause and ovarian cancer

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Noncontraceptive estrogen use and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Estrogen replacement therapy and risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Hormone replacement therapy and risk of epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Menopausal hormone replacement therapy and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Estrogen replacement therapy and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Endometrial cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Applying Cox Regression to Competing Risks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960534-0

7 January 2021

10.1016/S0140-6736(07)60534-0

Identifiers

DOI

1 reference

3 August 2017

1 reference